Frederico Gonçalves

Statistics

Publications

Citations

308

H-Index

Active since

2013

Affiliations

Oregon Health & Science University(Current)

Frederico Gonçalves is an author at Oregon Health & Science University specializing in medicine, prostate cancer, and prostate cancer hormonal therapy.

Publications per year

2013–2022

Publications

Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Prostate Cancer: The Primary Results of the PRONOUNCE Randomized Trial

Renato D. Lópes, Celestia S. Higano, Susan F. Slovin et al. · Circulation · 2021 · 143 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +13

Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer

Nicholas J. Vogelzang, Tomasz M. Beer, Winald R. Gerritsen et al. · JAMA Oncology · 2022 · 90 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Locally Advanced and Metastatic Prostate Cancer Treated with Intermittent Androgen Monotherapy or Maximal Androgen Blockade: Results from a Randomised Phase 3 Study by the South European Uroncological Group

Fernando Calais da Silva, Fernando Calais da Silva, Frederico Gonçalves et al. · European Urology · 2013 · 75 citations · Full text

Medicine, Oncology, Urology +17

1–3 of 3